MATTEO ACCORNERO was appointed to lead Luxottica’s retail business in ANZ a year ago and is now overseeing a major investment program across the company’s optical stores aimed at elevating the end-to-end customer experience.
Insight investigates the major challenges of accessing and sharing digital images captured on multiple ophthalmic devices, and whether proprietary interests take precedence over clinical convenience. Read more
In the second part of his series on frame adjustment, MURRAY O’BRIEN covers the most salient practical points that differ for various frame types and materials. Read more
When it comes to the treatment of glaucoma, there is growing evidence to suggest that the ability to re-establish the natural flow of aqueous humour plays a critical role not only in reducing IOP, but also in preserving the health of the corneal endothelium, says US ophthalmologist DR DAVID LUBECK.
George & Matilda Eyecare is primed to sign off on several new acquisitions as more independents see the value and safety of joining a collective in uncertain times. Read more
New eye drop formulations are making dry eye treatment more affordable and accessible, especially for more severe sufferers. But Australia has often played catch up, as RHIANNON BOWMAN reports.
In a new push for expanded scope-of-practice, Optometry Australia is calling for change in six areas – including oral medications and intravitreal injections – so the nation’s under-utilised optometric workforce can get to work tackling urgent eye health issues. Insight unpacks the organisation’s key proposals.
Australian optometrists are not permitted to prescribe oral medication, in contrast to comparative countries where their counterparts have been prescribing them for years. Insight investigates why this is the case in Australia.